PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: Analysts: Vytorin/Zetia sales will decline 25-50%
screen2largeMM

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.
.

PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.

Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Please read the terms of use agreement and privacy policy for this blog carefully.

Analysts: Vytorin/Zetia sales will decline 25-50%

Many analysts think Vytorin and Zetia sales will be affected through at least early 2009. But Timothy Anderson, who follows the company for Sanford Bernstein, said the market reaction is "overly pessimistic."

Some assumptions call for a decline in Vytorin/Zetia sales of 50 percent or more, Anderson said in a note to investors. More likely is a 25 percent drop by the end of 2009, with a greater falloff in the United States, he said.

"Does all of this mean that Vytorin/Zetia will become a near-dead franchise on life-support, like the market is suggesting?" he wrote. "Not likely. It will decline in value, however."

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home